As such, we hypothesized that due to the favorable effects on NK cells and the increase in CD70 expression upon CDDP treatment, the sequential administration of CDDP and aCD70 could increase antibody-coverage and improve NK-mediated lysis of the tumor cells [4]. The gene discussed is CD70; the disease is neoplasm.